John B. Rhodes, Director at Tonix Pharmaceuticals Holding Corp. (TNXP), bought 6,000 shares at $7.50 ($45K) on 2015-07-17, disclosed to the SEC on 2015-07-17.
Open-market purchase of $45k TNXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |